Research any topic before you write.

Find related topics. | Discover entities. | See connections. | Build a topical map.

Atomoxetine: History, Community, Culture & Applications

Atomoxetine, sold under the brand name Strattera, is a selective norepinephrine reuptake inhibitor (sNRI) medication used to treat attention deficit hyperactivity disorder (ADHD) and, to a lesser extent, cognitive disengagement syndrome (CDS). It may be used alone or along with psychostimulant medication. It enhances the executive functions of…

Language: English [EN]
Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.
100%
More settings
100% 100% 100% 100% 100%

Atomoxetine topic overview

The analysis highlights History, Community, Culture and Applications as prominent areas in the source structure around Atomoxetine.

Related topics
296
Source areas
9
Connected nodes
305
Extracted relationships
182
Concept neighborhoods
33
Bridge connections
305

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

Overview · 120 topics
Pharmacology · 45 topics
Research · 36 topics
Interactions · 34 topics
Side effects · 25 topics
Contraindications · 15 topics
Medical uses · 12 topics
Society and culture · 5 topics
History · 4 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

3D model (JSmol)
Interactive image
AHFS/Drugs.com
Monograph
ATC code
N06BA09 (WHO)
Bioavailability
2D6Tooltip CYP2D6 EMsTooltip extensive metabolizers: 94% 2D6Tooltip CYP2D6 PMsTooltip poor metabolizers: 63%
CAS Number
83015-26-3 Y · as HCl: 82248-59-7
ChEBI
CHEBI:127342 Y · as HCl: CHEBI:331697

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

Medical uses

Contraindications

Side effects

Interactions

Pharmacology

History

Society and culture

Research

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

How Atomoxetine connects Entity context

The extracted context around Atomoxetine shows recurring relationship patterns in the source. For example, Atomoxetine → Atentah, Atominex, Attentin, Attera, Attex, Auroxetyn, Axepta, Axetra, Canada, Czech Republic, France, In, In Australia, In Brazil, In France, In India, In Indonesia, In Iran, In Poland, In Turkey Another extracted example is Atomoxetine → ADHD, August, Company, Eli Lilly, FDA, HCl, In, It, Its, July, Lilly, May, On, September, Strattera, Sun Pharmaceutical's Chairman, Sun Pharmaceuticals, United States, US. Use these groups to spot repeated connection types before inspecting the individual relationships.

Atomoxetine

Top relations

related to Names · 34
Atomoxetine → Atentah, Atominex, Attentin, Attera, Attex, Auroxetyn, Axepta, Axetra, Canada, Czech Republic, France, In, In Australia, In Brazil, In France, In India, In Indonesia, In Iran, In Poland, In Turkey
related to history · 19
Atomoxetine → ADHD, August, Company, Eli Lilly, FDA, HCl, In, It, Its, July, Lilly, May, On, September, Strattera, Sun Pharmaceutical's Chairman, Sun Pharmaceuticals, United States, US
related to Interactions · 16
Atomoxetine → Bupropion, Concurrent, CYP1A2, CYP2C9, CYP2D6, CYP3A, CYP3A4, CYP450, Dosage, Findings, It, N-desmethylatomoxetine, O-glucuronide, P-glycoprotein, P450, Similarly
related to Pharmacodynamics · 11
Atomoxetine → Atomoxetine's, Conversely, DAT, DRI, However, In, NET, PET, SERT, Subsequently, Supporting
related to Research · 11
Atomoxetine → ADHD, Alzheimer's, Besides, Company, Eli Lilly, However, It, Parkinson's, SSRIs, The, Though
related to Attention deficit hyperactivity disorder · 9
Atomoxetine → ADHD, Doctors, However, In, It, Meta-analyses, One, The, While
Legal status · 7
Atomoxetine → AU: S4 (Prescription only), BR: Class C1 (Other controlled substances), CA: ℞-only, EU: Rx-only, NZ: Prescription only, UK: POM (Prescription only), US: ℞-only
has effect · 5
Atomoxetine → ADHD, As, Common, CYP2D6, The
related to Contraindications · 5
Atomoxetine → Any, Contraindications, MAOIs, Moderate, Narrow-angle
CAS Number · 2
Atomoxetine → 83015-26-3 Y, as HCl: 82248-59-7

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

cyp2d6 metabolizers poor adhd extensive found may effects levels treatment exposure used 4-hydroxyatomoxetine hours increase inhibitors drug metabolism however brand

Atomoxetine relationships Subject–Predicate–Object triples

TTTA extracted 182 structured relationships around Atomoxetine. Examples in this analysis include Atomoxetine → 3D model (JSmol) → Interactive image and Atomoxetine → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.

SubjectPredicateObjectConfidenceSrc
Atomoxetine3D model (JSmol)Interactive image1.00infobox
AtomoxetineAHFS/Drugs.comMonograph1.00infobox
AtomoxetineATC codeN06BA09 (WHO)1.00infobox
AtomoxetineBioavailability2D6Tooltip CYP2D6 EMsTooltip extensive metabolizers: 94% 2D6Tooltip CYP2D6 PMsTooltip poor metabolizers: 63%1.00infobox
AtomoxetineCAS Number83015-26-3 Y1.00infobox
AtomoxetineCAS Numberas HCl: 82248-59-71.00infobox
AtomoxetineChEBICHEBI:127342 Y1.00infobox
AtomoxetineChEBIas HCl: CHEBI:3316971.00infobox
AtomoxetineChEMBLChEMBL641 Y1.00infobox
AtomoxetineChEMBLas HCl: ChEMBL17021.00infobox
AtomoxetineChemSpider49516 Y1.00infobox
AtomoxetineChemSpideras HCl: 495151.00infobox
AtomoxetineCompTox Dashboard (EPA)DTXSID90442971.00infobox
AtomoxetineDrug classNorepinephrine reuptake inhibitor (NRI)1.00infobox
AtomoxetineDrugBankDB00289 Y1.00infobox
AtomoxetineDrugBankas HCl: DBSALT0012071.00infobox
AtomoxetineECHA InfoCard100.120.3061.00infobox
AtomoxetineElimination half-life2D6Tooltip CYP2D6 EMsTooltip extensive metabolizers: 4.5–5.3 h 2D6Tooltip CYP2D6 PMsTooltip poor metabolizers: 19–22 h1.00infobox
AtomoxetineExcretion2D6Tooltip CYP2D6 EMsTooltip extensive metabolizers: urine (>96%), feces (1–2%) 2D6Tooltip CYP2D6 PMsTooltip poor metabolizers: urine (80%), feces (13–22%)1.00infobox
AtomoxetineFormulaC17H21NO1.00infobox
AtomoxetineIUPHAR/BPS71181.00infobox
AtomoxetineKEGGD07473 Y1.00infobox
AtomoxetineKEGGas HCl: D025741.00infobox
AtomoxetineLegal statusAU: S4 (Prescription only)1.00infobox
AtomoxetineLegal statusBR: Class C1 (Other controlled substances)1.00infobox
AtomoxetineLegal statusCA: ℞-only1.00infobox
AtomoxetineLegal statusNZ: Prescription only1.00infobox
AtomoxetineLegal statusUK: POM (Prescription only)1.00infobox
AtomoxetineLegal statusUS: ℞-only1.00infobox
AtomoxetineLegal statusEU: Rx-only1.00infobox

Related concept clusters Concept neighborhoods

The concept neighborhoods around Atomoxetine bring nearby vocabulary together. In this analysis, examples include Cyp2d6, Found and Metabolizers. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

  • Atomoxetine
    • Cyp2d6
    • Found
    • Metabolizers
    • Levels
    • Treatment
    • Extensive
    • Poor
    • Effects
    • May
    • Adhd
    • Exposure
    • Increase
  • atomoxetine
    • Cyp2d6
    • Found
    • Metabolizers
    • Levels
    • Treatment
    • Extensive
    • Poor
    • Effects
    • May
    • Adhd
    • Exposure
    • Increase
  • selective norepinephrine reuptake inhibitor
    • Reuptake
    • Inhibitors
    • Effects
    • Strattera
    • N-desmethylatomoxetine
    • Levels
    • Drug
    • Used
    • 4-hydroxyatomoxetine
    • Treatment
    • Medication
    • Bioavailability
  • cyp2d6
    • Metabolizers
    • Poor
    • Extensive
    • Levels
    • 4-hydroxyatomoxetine
    • Hours
    • Metabolism
    • Status
    • N-desmethylatomoxetine
    • Inhibitors
    • Peak
    • Excreted
  • poor metabolizers
    • Poor
    • Hours
    • Levels
    • Peak
    • 4-hydroxyatomoxetine
    • N-desmethylatomoxetine
    • Excreted
    • Urine
    • Side
    • Inhibitors
    • Exposure
    • Metabolites
  • extensive metabolizers
    • Poor
    • Metabolizers
    • Levels
    • Peak
    • Hours
    • 4-hydroxyatomoxetine
    • Urine
    • Metabolism
    • N-desmethylatomoxetine
    • Excreted
    • Status
    • Exposure
  • norepinephrine transporter
    • Reuptake
    • Effects
    • Strattera
    • N-desmethylatomoxetine
    • Inhibitors
    • Drug
    • 4-hydroxyatomoxetine
    • Levels
    • Medication
    • Bioavailability
    • Include
    • Urine
  • side effects
    • Side
    • Include
    • Norepinephrine
    • May
    • Including
    • Reuptake
    • Drug
    • Found
    • Poor
    • Treatment
    • Metabolizers
    • Bioavailability

Connections between topic areas Semantic bridges

For Atomoxetine, one of the stronger structural bridges in this analysis connects Atomoxetine with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3
Atomoxetine — Overview · splits 185 ⟂ 121
Atomoxetine — Pharmacology · splits 260 ⟂ 46
Atomoxetine — Research · splits 269 ⟂ 37
Atomoxetine — Interactions · splits 271 ⟂ 35
Atomoxetine — Side effects · splits 280 ⟂ 26
Atomoxetine — Contraindications · splits 290 ⟂ 16
Atomoxetine — Medical uses · splits 293 ⟂ 13
Atomoxetine — Society and culture · splits 300 ⟂ 6
Atomoxetine — History · splits 301 ⟂ 5

Map overview Semantic statistics

Atomoxetine

Nodes306
Edges305
Triples182
Avg. degree1.99
Density0.006536
Components1

Source & methodology

TTTA analyzes the structure around Atomoxetine to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Community, Culture & Applications, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Atomoxetine · EN edition · Analysis: TopicsToTalkAbout

For writers, content strategists, SEOs, marketers and creators — from quick topic research to advanced semantic analysis.